Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Neuroprotective Effect of Artesunate in Experimental Model of Traumatic Brain Injury 2018-07-31
  2. Cerebrovascular pathology during the progression of experimental Alzheimer's disease 2016-01-08
  3. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation 2014-01-01

Studies

5 studies carry this tag.

Date range

2008 to 2018

Top journals

  • CNS & neurological disorders drug targets 1
  • Frontiers in neurology 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of neurotrauma 1
  • Neurobiology of disease 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neuroprotective Effect of Artesunate in Experimental Model of Traumatic Brain Injury

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Frontiers in neurology 2018-07-31 Biomarkers

    Traumatic brain injuries (TBI) are an important public health challenge.

  2. Cerebrovascular pathology during the progression of experimental Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neurobiology of disease 2016-01-08 Biomarkers

    Clinical and experimental evidence point to a possible role of cerebrovascular dysfunction in Alzheimer's disease (AD).

  3. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. CNS & neurological disorders drug targets 2014-01-01 Biomarkers

    Pre-treatment with co-ultraPEALut significantly reduced inducible nitric oxide synthase and glial fibrillary acidic protein expression, restored neuronal nitric oxide synthase and brainderived neurotrophic factor and reduced the apoptosis.

  4. Screening of biochemical and molecular mechanisms of secondary injury and repair in the brain after experimental blast-induced traumatic brain injury in rats

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurotrauma 2013-06-05 Biomarkers

    Ascorbate, LMWT, and protein thiols were reduced at 2 and 24 h; by 24 h, HNE was increased.

  5. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2008-09-01 Biomarkers

    Alzheimer's disease (AD) is associated with brain insulin resistance and insulin deficiency, whereas Type 2 diabetes mellitus (T2DM) is associated with peripheral insulin resistance.

All topic tags with their study counts